Siemens presents new MR applications for Oncology

Siemens Healthcare exhibits its latest solutions in the field of Magnetic Resonance (MR) for Oncology at the European Radiology Congress ECR 2009 in Vienna. The syngo TimCT Oncology application enables not only comprehensive patient examinations within extreme short examination time possible, it can also eliminate the need for multiple examinations with other modalities.

Photo: Siemens presents new MR applications for Oncology

The syngo Tissue 4D software supports tissue differentiation of prostate cancer. In addition, Siemens presents innovative technologies in the area of Women's Health: dedicated breast coils for 1.5 Tesla and 3 Tesla systems as well as the new breast scanner Magnetom Espree - Pink. The 1.5T ystem combines a 70cm Open-Bore design with a dedicated breast care solution. Particularly for obese and claustrophobic patients, the large bore makes examinations more comfortable than with previous systems, or, in some cases, it makes them possible for the first time ever.
 

05.03.2009

More on the subject:More on companies:

Related articles

Photo

Sponsored • New Whitepaper

AI-Enabled Care Pathway: Shifting the Paradigm in Prostate Cancer Diagnosis

Prostate cancer is the second most common cancer in men worldwide. As clinical guidelines increasingly recommend MRI before biopsy, prostate MRI has become a critical decision point in the diagnostic…

Photo

Article • Equity, access, and the future of radiotherapy

Radiation oncology: the beam widens

Radiation oncology is a field in remarkable transformation: a deepening global shortage of trained practitioners, persistent inequities in access to treatment – and, on the other side of the…

Photo

Sponsored • Earlier disease prediction and identification

The potential of AI in routine blood testing

It’s widely known that more than 70% of today’s medical decisions involve the results of laboratory tests, but the insights clinicians derive from these tests today may only be scratching the…

Subscribe to Newsletter